HIV-Associated Lipodystrophy Syndrome
"HIV-Associated Lipodystrophy Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
| Descriptor ID |
D039682
|
| MeSH Number(s) |
C02.782.815.616.400.400 C02.800.801.400.400 C17.800.849.391.400 C18.452.584.625.400 C18.452.880.391.400 C20.673.480.400
|
| Concept/Terms |
HIV-Associated Lipodystrophy Syndrome- HIV-Associated Lipodystrophy Syndrome
- HIV Associated Lipodystrophy Syndrome
- Lipodystrophy Syndrome, HIV-Associated
- HIV Lipodystrophy Syndrome
- HIV-Associated Lipodystrophy
- HIV Associated Lipodystrophy
- Lipodystrophy, HIV-Associated
- Lipodystrophy Syndrome, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV-Associated Lipodystrophy Syndrome".
Below are MeSH descriptors whose meaning is more specific than "HIV-Associated Lipodystrophy Syndrome".
This graph shows the total number of publications written about "HIV-Associated Lipodystrophy Syndrome" by people in this website by year, and whether "HIV-Associated Lipodystrophy Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV-Associated Lipodystrophy Syndrome" by people in Profiles.
-
Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review. J Clin Endocrinol Metab. 2017 Feb 01; 102(2):363-374.
-
Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. Metabolism. 2013 Jul; 62(7):1014-20.
-
Phase I study of nelfinavir in liposarcoma. Cancer Chemother Pharmacol. 2012 Dec; 70(6):791-9.
-
Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome. Metabolism. 2012 Oct; 61(10):1395-403.
-
Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBP? mRNA. Obesity (Silver Spring). 2012 Feb; 20(2):253-62.
-
Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study. Metabolism. 2011 Jun; 60(6):754-60.
-
HIV type-1 transgene expression in mice alters adipose tissue and adipokine levels: towards a rodent model of HIV type-1 lipodystrophy. Antivir Ther. 2010; 15(7):1021-8.
-
Drug-induced paraparotid fat deposition in patients with HIV: case reports. J Am Dent Assoc. 2008 Feb; 139(2):152-7.
-
HIV-associated facial lipoatrophy: establishment of a validated grading scale. Laryngoscope. 2007 Aug; 117(8):1349-53.
-
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia. Contemp Clin Trials. 2006 Dec; 27(6):518-30.